LONDON--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...
Dexcom said it is working with insulin pump manufacturers to integrate its new G7 sensor into current and future automated artificial pancreas systems. (Dexcom) Dexcom has obtained European approval ...
Dexcom’s new sensor is being developed to last 15 days—longer than the 10-day life span of its recently launched G7 CGM, pictured here. The new sensor will also be equipped with a different software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results